Kathleen Rubinstein
Senior Analyst, Health Care
Norton Rose Fulbright US LLP
Related services and key industries
Biography
Kathleen P. Rubinstein is a senior health care analyst in Norton Rose Fulbright's Houston office. Working with clients in navigating the uncertainties of a shifting regulatory landscape, Kathleen focuses on the regulation and financing of the Medicare and Medicaid programs, implementation of the Affordable Care Act, federal and state approaches to health care regulation and reform and government-led responses to the COVID-19 pandemic. She oversees and consults on a variety of projects and initiatives involving the organization, financing and structure of the US health care system and applies her frontline understanding of policy issues in supporting research and analysis.
Since 2002, Kathleen has served as an adjunct faculty member of the University of Houston's Master of Public Administration program, where she instructs graduate students on the application of policy analysis tools and approaches to contemporary problems in US health care.
Professional experience
Collapse allMA, University of Houston, 1996
BA, Our Lady of the Lake University, 1992
- Award for Teaching Excellence in Healthcare Policy, University of Houston Master of Public Administration Program, 2019
- Recognition Award in appreciation of establishing the Best Paper Award, University of Houston Master of Public Administration Program, 2011
- Sponsor, Kathleen Rubinstein Best Paper Award, University of Houston MPA Alumni Association
- American Health Lawyers Association, Member
- American Hospital Association, Member
- University of Houston Alumni Association, Life Member
- University of Houston MPA Alumni Association, Founding Member
- Board of Directors (2016-2019)
Insights
Joint Commission updates lab proficiency testing requirements
Publication | November 01, 2024
GAO: CMS cannot assure hospital pricing data is accurate or complete
Publication | October 22, 2024
Nursing care centers: New emergency management standards released
Publication | September 20, 2024